HSG Holding Ltd

Fundamental concentrated ★Highest signal services_media specialist (71%) CIK 1470766
League rank
#1025
in Fundamental concentrated · #7465 overall
Long book
$1.62B
Q1 2026
Positions
20
Top-10 weight
98%
concentration
Last quarter
-15.6%
SPY +14.8%
Turnover
14%
of book per quarter

Strategy in plain words

auto-generated from filings

HSG Holding Ltd is a concentrated fundamental stock-picker, specialised in services_media (71% of the long book), running a $1.62B US long book across 20 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is modest: positions are typically held for years. Current anchor positions: PDD HOLDINGS INC, KE HOLDINGS INC-ADR, PONY AI INC, FUTU HOLDINGS LTD-ADR, WEBULL CORP.

Over the last 9 quarters its long book ran on average 6pp per quarter behind the S&P 500, beating the index in 3 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
+9.6%
Q2 2024
+4.6%
Q3 2024
-21.6%
Q4 2024
+19.4%
Q1 2025
-8.1%
Q2 2025
+27.5%
Q3 2025
-15.2%
Q4 2025
-14.0%
Q1 2026
-15.6%

Sector allocation

Financials
83%
Healthcare
11%
Consumer discretionary
6%
Technology
0%

Long book by quarter

$1.08B
Q1 2024
$2.71B
Q2 2024
$2.58B
Q3 2024
$2.42B
Q4 2024
$1.70B
Q1 2025
$1.94B
Q2 2025
$1.92B
Q3 2025
$1.89B
Q4 2025
$1.62B
Q1 2026

What does HSG Holding own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
BULL WEBULL CORPFinancials7.1M$55.2M3.4%Held
CRCL CIRCLE INTERNET GROUP INCFinancials669.2K$48.7M3.0%+114.3%
AVBP ARRIVENT BIOPHARMA INCHealthcare663.3K$14.0M0.9%Held
THCH TH INTERNATIONAL LTD/CAYMANConsumer discretionary2.9M$7.5M0.5%Held
BTDR BITDEER TECHNOLOGIES GROUP-AFinancials293.7K$2.9M0.2%Held
YMT YIMUTIAN INCTechnology3.4M$544K0.0%New
LYEL LYELL IMMUNOPHARMA INCHealthcare152.3K$73K0.0%Held

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 15, 202626$1.62B canonicalSEC ↗
Q4 202513F-HRFeb 13, 202625$902.0M canonicalSEC ↗
Q3 202513F-HRNov 14, 202526$1.92Bconfidential canonicalSEC ↗
Q2 202513F-HRAug 14, 202523$1.94B canonicalSEC ↗
Q1 202513F-HRMay 13, 202523$1.70B canonicalSEC ↗
Q4 202413F-HRFeb 14, 202525$2.42B canonicalSEC ↗
Q3 202413F-HRNov 13, 202426$2.58B canonicalSEC ↗
Q2 202413F-HRAug 13, 202425$2.71B canonicalSEC ↗
Q1 202413F-HRMay 15, 202426$1.08B canonicalSEC ↗